Shugeng Cao
- Pharmacology top 0.2%
- Microbial Natural Products and Biosynthesis 63
- Fungal Biology and Applications 29
- Biotechnology top 0.5%
- Marine Sponges and Natural Products 35
- Toxicology top 0.5%
- Biochemistry top 1%
- Molecular Biology top 2%
- Natural product bioactivities and synthesis 34
- Phytochemical compounds biological activities 16
- Plant biochemistry and biosynthesis 12
-
- Phytochemistry and Biological Activities 27
- Natural Compound Pharmacology Studies 16
- Co-authors
- Jon ClardyRoberto KolterDavid G. I. KingstonRichard LosickIlana Kolodkin‐GalDiego RomeroChun‐Shun LiJames S. Miller
- Cited by
- PharmacologyBiotechnologyToxicology
- Journals
- Nature (1 paper)Science (1 paper)Proceedings of the National Academy of Sciences (3 papers)
- Partner nations
- United StatesChinaSingapore
In The Last Decade
Shugeng Cao
175 papers receiving 5.3k citations
Hit Papers
Peers
Comparison fields: 5 of 148
- Pharmacology 1.6k
- Biotechnology 795
- Toxicology 212
- Biochemistry 379
- Molecular Biology 2.7k
Countries citing papers authored by Shugeng Cao
This map shows the geographic impact of Shugeng Cao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shugeng Cao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shugeng Cao more than expected).
Fields of papers citing papers by Shugeng Cao
This network shows the impact of papers produced by Shugeng Cao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shugeng Cao. The network helps show where Shugeng Cao may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Shugeng Cao, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 10 | |
| 3 | 2023 | 1 | |
| 4 | 2023 | 1 | |
| 5 | 2022 | 30 | |
| 6 | 2022 | 13 | |
| 7 | 2022 | 34 | |
| 8 | 2021 | 13 | |
| 9 | 2021 | 7 | |
| 10 | 2021 | 27 | |
| 11 | 2020 | 13 | |
| 12 | 2020 | 12 | |
| 13 | 2020 | 24 | |
| 14 | 2020 | 9 | |
| 15 | 2019 | 17 | |
| 16 | 2017 | 31 | |
| 17 | Small-Molecule Reactivation of Mutant p53 to Wild-Type-like p53 through the p53-Hsp40 Regulatory Axis | 2015 | 3 |
| 18 | 2011 | 20 | |
| 19 | 2010 | 688 | |
| 20 | 2009 | 16 |
About Shugeng Cao
Shugeng Cao is a scholar working on Biotechnology, Pharmacology and Toxicology, having authored 177 papers that have together received 5.4k indexed citations. Recurring topics across this work include Microbial Natural Products and Biosynthesis (63 papers), Marine Sponges and Natural Products (35 papers), Natural product bioactivities and synthesis (34 papers), Fungal Biology and Applications (29 papers), Phytochemistry and Biological Activities (27 papers), Natural Compound Pharmacology Studies (16 papers), Phytochemical compounds biological activities (16 papers) and Plant biochemistry and biosynthesis (12 papers). The work is most often cited by research in Pharmacology (1.6k citations), Biotechnology (795 citations) and Toxicology (212 citations). Shugeng Cao has collaborated with scholars based in United States, China and Singapore. Frequent co-authors include Jon Clardy, Roberto Kolter, David G. I. Kingston, Richard Losick, Ilana Kolodkin‐Gal, Diego Romero, Chun‐Shun Li, James S. Miller, Vincent E. Rasamison and Ki Hyun Kim. Their work appears in journals such as Nature, Science and Proceedings of the National Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.